4//SEC Filing
BOBULSKY SUSAN 4
Accession 0001209191-20-063101
CIK 0001478320other
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 9:00 PM ET
Size
8.8 KB
Accession
0001209191-20-063101
Insider Transaction Report
Form 4
BOBULSKY SUSAN
Chief Commercial Officer, MRD
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2020-12-10−25,000→ 30,000 totalExercise: $1.98Exp: 2024-10-13→ Common Stock (25,000 underlying) - Exercise/Conversion
Common Stock
2020-12-10$1.98/sh+25,000$49,500→ 25,000 total - Sale
Common Stock
2020-12-10$55.00/sh−25,000$1,375,000→ 0 total
Footnotes (2)
- [F1]These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2019.
- [F2]All options are fully exercisable.
Documents
Issuer
Adaptive Biotechnologies Corp
CIK 0001478320
Entity typeother
Related Parties
1- filerCIK 0001820885
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 9:00 PM ET
- Size
- 8.8 KB